A Combination of the Tryptophan Hydroxylase Inhibitor Telotristat with the mTOR Inhibitor Everolimus as an Effective Strategy Against Neuroendocrine Tumors.
Saved in:
| Title: | A Combination of the Tryptophan Hydroxylase Inhibitor Telotristat with the mTOR Inhibitor Everolimus as an Effective Strategy Against Neuroendocrine Tumors. |
|---|---|
| Authors: | Molina-Cerrillo, Javier1 (AUTHOR) Javier.molinace@gmail.com, Sierra-Ramirez, Arantzazu2 (AUTHOR), López-Aceituno, José L.2 (AUTHOR), Méndez-Pertuz, Marinela3 (AUTHOR), Alonso-Gordoa, Teresa1 (AUTHOR), Linnebacher, Michael4 (AUTHOR), Santoni, Matteo5 (AUTHOR), Fernandez-Marcos, Pablo J.2 (AUTHOR) pablojose.fernandez@imdea.org, Grande, Enrique6 (AUTHOR) egrande@oncomadrid.com |
| Source: | Drugs in R&D. May2026, p1-13. 13p. |
| Database: | Academic Search Ultimate |
| FullText | Links: – Type: pdflink Text: Availability: 0 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 193973447 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Combination of the Tryptophan Hydroxylase Inhibitor Telotristat with the mTOR Inhibitor Everolimus as an Effective Strategy Against Neuroendocrine Tumors. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Molina-Cerrillo%2C+Javier%22">Molina-Cerrillo, Javier</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> Javier.molinace@gmail.com</i><br /><searchLink fieldCode="AR" term="%22Sierra-Ramirez%2C+Arantzazu%22">Sierra-Ramirez, Arantzazu</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22López-Aceituno%2C+José+L%2E%22">López-Aceituno, José L.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Méndez-Pertuz%2C+Marinela%22">Méndez-Pertuz, Marinela</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Alonso-Gordoa%2C+Teresa%22">Alonso-Gordoa, Teresa</searchLink><relatesTo>1</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Linnebacher%2C+Michael%22">Linnebacher, Michael</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Santoni%2C+Matteo%22">Santoni, Matteo</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Fernandez-Marcos%2C+Pablo+J%2E%22">Fernandez-Marcos, Pablo J.</searchLink><relatesTo>2</relatesTo> (AUTHOR)<i> pablojose.fernandez@imdea.org</i><br /><searchLink fieldCode="AR" term="%22Grande%2C+Enrique%22">Grande, Enrique</searchLink><relatesTo>6</relatesTo> (AUTHOR)<i> egrande@oncomadrid.com</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Drugs+in+R%26D%22">Drugs in R&D</searchLink>. May2026, p1-13. 13p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=193973447 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1007/s40268-026-00544-x Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 13 StartPage: 1 Titles: – TitleFull: A Combination of the Tryptophan Hydroxylase Inhibitor Telotristat with the mTOR Inhibitor Everolimus as an Effective Strategy Against Neuroendocrine Tumors. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Molina-Cerrillo, Javier – PersonEntity: Name: NameFull: Sierra-Ramirez, Arantzazu – PersonEntity: Name: NameFull: López-Aceituno, José L. – PersonEntity: Name: NameFull: Méndez-Pertuz, Marinela – PersonEntity: Name: NameFull: Alonso-Gordoa, Teresa – PersonEntity: Name: NameFull: Linnebacher, Michael – PersonEntity: Name: NameFull: Santoni, Matteo – PersonEntity: Name: NameFull: Fernandez-Marcos, Pablo J. – PersonEntity: Name: NameFull: Grande, Enrique IsPartOfRelationships: – BibEntity: Dates: – D: 24 M: 05 Text: May2026 Type: published Y: 2026 Identifiers: – Type: issn-print Value: 11745886 Titles: – TitleFull: Drugs in R&D Type: main |
| ResultId | 1 |
